Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1692234 Seattle, WA
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$520,513
+$459,809 QoQ
Shares Held
28,584
+569.1% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#95
of 183 holders
Holding Since
Mar 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. CGEM ranks #150 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in CGEM

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $520,513 28,584
2026-03-31 $60,704 4,272
2025-12-31 $252,631 24,409
2025-09-30 $25,332 4,272
2025-06-30 $308,623 40,986
2025-03-31 $222,277 29,363
2024-06-30 $598,068 34,293
2023-12-31 $23,437 2,300
2023-06-30 $234,395 21,784
2023-03-31 $22,362 2,186